FDA NDC Directory · JSON-LD · Markdown

Cefazolin

NDC 44567-845 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Labeler / ManufacturerWG Critical Care, LLC
Marketing categoryNew Drug Application (innovator) · App NDA211413
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsCEFAZOLIN SODIUM (3 g/1)
Marketing started20240510
Package count1

External sources

Source: openFDA. Public-domain (CC0).